HuGE Literature Finder
Records
1
-
5
| Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer. Scientific reports 2022 02 12 (1): 2167. Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Korphaisarn Krittiya, Leelayuwatanakul Nophol, Pornpatrananrak Nopporn, Poungvarin Naravat, Chantranuwat Poonchavist, Shuangshoti Shanop, Aporntewan Chatchawit, Chintanapakdee Wariya, Sriuranpong Virote, Vinayanuwattikun Chani |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Plasma MiRNA alterations between NSCLC patients harboring Del19 and L858R EGFR mutations. Oncotarget 2016 Jul . Ma Yihan, Xu Peiqi, Mi Yanjun, Wang Wenyi, Pan Xiaoyan, Wu Xiaoting, He Qi, Liu Hongming, Tang Weiwei, An Hanxia |
| Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 32-7. Ma Hongxia, Chen Jiaping, Pan Shiyang, Dai Juncheng, Jin Guangfu, Hu Zhibin, Shen Hongbing, Shu Yongqi |
| Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. BMC medical genomics 2008 Jun 1 (1): 25. Blons H, Pallier K, Le Corre D, Danel C, Tremblay M, Houdayer C, Fabre-Guillevin E, Riquet M, Dessen P, Laurent-Puig P |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: